We are live on ! Find out more
BCM

Boxer Capital Management Portfolio holdings

AUM $1.33B
1-Year Est. Return 864.5%
This Fund
S&P 500
This Quarter Est. Return
+54.02%
1 Year Est. Return
+864.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$762M
AUM Growth
+$305M
Cap. Flow
+$141M
Cap. Flow %
18.47%
Top 10 Hldgs %
63.32%
Holding
56
New
11
Increased
13
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
PCVX icon
Vaxcyte
PCVX
+$17.6M
2
CRVS icon
Corvus Pharmaceuticals
CRVS
+$17.6M
3
RVMD icon
Revolution Medicines
RVMD
+$10.1M
4
VIR icon
Vir Biotechnology
VIR
+$9.89M
5
CORT icon
Corcept Therapeutics
CORT
+$9.35M

Top Sells

Rank Stock Value
1
CDTX
Cidara Therapeutics
CDTX
+$11.7M
2
PEPG icon
PepGen
PEPG
+$568K
3
HELP
Cybin Inc
HELP
+$485K
4
NUVB.WS
Nuvation Bio Inc Warrants
NUVB.WS
+$88K
5
INO icon
Inovio Pharmaceuticals
INO
+$82.3K

Sector Composition

Rank Sector Weight
1 Healthcare 99.69%
2 Consumer Staples 0.31%
3 Miscellaneous 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEPG icon
51
PepGen
PEPG
$213M
$483K 0.06%
272,892
-101,000
-27% -$568K
KALV
52
DELISTED
KalVista Pharmaceuticals
KALV
$411K 0.05%
20,400
– –
RGNX icon
53
Regenxbio
RGNX
$638M
$126K 0.02%
+15,000
New +$158K
SRZNW
54
DELISTED
Surrozen Inc Warrant
SRZNW
$1.07K ﹤0.01%
66,666
– –
CDTX
55
DELISTED
Cidara Therapeutics
CDTX
– –
-53,000
Closed -$11.7M
NUVB.WS
56
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
– –
-266,666
Closed -$88K
1 2
3

Similar funds

BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CA
Callahan Advisors Houston, Texas $1.33B AUM 29.71% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.33B AUM 37.42% 1-Year Est. Return
MIC
Means Investment Company Bangor, Maine $1.32B AUM 24.33% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.32B AUM 30.92% 1-Year Est. Return
OCM
Ovata Capital Management Hong Kong $1.33B AUM 5.69% 1-Year Est. Return
GAMA
Graticule Asia Macro Advisors New York $1.33B AUM 1,044.61% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.33B AUM 19.79% 1-Year Est. Return

Boxer Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Boxer Capital Management held 56 positions worth $762M, up 67% from $457M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Boxer Capital Management deployed $141M of net new capital in Q1 2026, opening 11 new positions and adding to 13 existing holdings. Its largest new stake was Vaxcyte: 325,000 shares worth $18.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier, followed by Consumer Staples and Miscellaneous.

On the sell side, the largest reduction was PepGen, an estimated $568K trimmed.

  • Boxer Capital Management's largest Q1 2026 buy was Vaxcyte: 325,000 shares worth $18.9M.
  • Boxer Capital Management added most to Revolution Medicines in Q1 2026, an estimated $10.1M increase.
  • Boxer Capital Management's biggest Q1 2026 reduction was PepGen, cutting an estimated $568K.
  • Boxer Capital Management fully exited Cidara Therapeutics in Q1 2026, selling an estimated $11.7M.
  • Boxer Capital Management's ten largest holdings make up 63% of its $762M portfolio in Q1 2026.
  • Boxer Capital Management opened 11 new positions and closed 2 in Q1 2026.
  • Boxer Capital Management's portfolio value rose 67% quarter-over-quarter to $762M.

Based on Boxer Capital Management's 13F filing for Q1 2026, filed 15 May 2026.